ArticleJournal of diabetes investigation2026
WTAP-mediated m6A RNA methylation promotes diabetic foot ulcer healing under negative pressure wound therapy.
Article in Journal of diabetes investigation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
aimsTo investigate the role of RNA N6-methyladenosine (m6A) methyltransferase Wilms tumor 1-associated protein (WTAP) in negative pressure wound therapy (NPWT) for diabetic foot ulcers (DFU). MATERIALS AND
methodsWe enrolled 46 DFU patients and 16 non-diabetic chronic ulcer patients treated with NPWT. Total m6A levels and the expression of methyltransferases (METTL3, METTL14, and WTAP) in wound margin tissues were measured before and after NPWT. High glucose-induced HaCaT and HDF cell models, alongside an in vitro negative pressure system, were used to evaluate the effect of negative pressure on WTAP expression and the impact of WTAP alteration on cellular functions.
resultsBefore NPWT, METTL3, METTL14, WTAP and m6A levels were significantly lower in DFU patients than in the non-diabetic chronic ulcer patients. After one week of NPWT, these parameters increased significantly in both groups, and a positive correlation was observed between WTAP and m6A levels. Notably, the increase in WTAP expression exhibited a significant positive correlation with the 4-week healing outcome in DFU patients. In vitro, negative pressure significantly reversed the high glucose-induced WTAP downregulation in both HaCaT and HDF cells, while WTAP knockdown profoundly impaired their proliferation and migration.
conclusionsNPWT is associated with improved DFU healing and the restoration of WTAP-m6A levels, and its effect may be related to negative pressure promoting WTAP expression to enhance wound cell proliferation and migration.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.